New Delhi:
Coronavirus Cases Today: India reported 62,480 new COVID-19 circumstances within the final 24 hours. Daily recoveries proceed to outnumber the each day new circumstances for the thirty sixth consecutive day because the second wave of infections look like ebbing.
Here are the highest 10 updates on coronavirus in India:(*73*)
-
India’s each day take a look at positivity fee – constructive circumstances recognized for each 100 exams – continues to say no. It stood at 3.24 per cent – under 5 per cent for the eleventh straight day.
-
Maharashtra leads the states with the best variety of infections. It is adopted by Karnataka, Kerala, Tamil Nadu and Andhra Pradesh.
-
At current, there are 20 states and union territories the place the Covid energetic caseload is lower than 5,000 and a drastic discount is being famous in virtually all states.
-
Prime Minister Narendra Modi will launch a personalized crash course programme for COVID-19 frontline staff at present by way of video conferencing, the Prime Minister’s Office (PMO) mentioned. The programme goals to ability and upskill over one lakh “Covid warriors” throughout the nation, the PM’s Office mentioned.
-
The Serum Institute of India, which is making ready to provide Novavax’s COVID-19 vaccine within the nation underneath the title Covovax, plans to begin trials of the vaccine on youngsters subsequent month, sources within the firm instructed NDTV on Thursday.
-
Biological E’s made-in-India vaccine is predicted to have 90 per cent effectiveness in opposition to Covid and can possible be a gamechanger within the battle in opposition to the pandemic, says a prime physician on a authorities advisory panel. NK Arora, chairperson of the Centre’s Covid Working Group, has mentioned that the vaccine is getting into Phase 3 trials and might be accessible by October.
-
The Uttarakhand authorities on Thursday lodged a case in opposition to an organization and two personal labs for fudging coronavirus take a look at reviews in the course of the Haridwar Kumbh Mela in April.
-
A commentary on the web site of the medical journal The Lancet authored by 21 individuals, together with Biocon’s Kiran Mazumdar Shaw and prime surgeon Dr Devi Shetty, has really useful eight actions to organize for a potential resurgence of COVID-19 circumstances in India.
-
The Russian Direct Investment Fund (RDIF) has mentioned its Covid vaccine Sputnik V will quickly provide a booster shot or the second dose of the vaccine, which has been adjusted to work in opposition to the Delta variant of coronavirus, to different vaccine producers. In April, Sputnik obtained emergency use authorisation in India, making it the third vaccine to be made accessible within the nation.
-
India’s each day take a look at positivity fee – constructive circumstances recognized for each 100 exams – continues to say no. It stood at 3.24 per cent – under 5 per cent for the eleventh straight day.
-
Maharashtra leads the states with the best variety of infections. It is adopted by Karnataka, Kerala, Tamil Nadu and Andhra Pradesh.
-
At current, there are 20 states and union territories the place the Covid energetic caseload is lower than 5,000 and a drastic discount is being famous in virtually all states.
-
Prime Minister Narendra Modi will launch a personalized crash course programme for COVID-19 frontline staff at present by way of video conferencing, the Prime Minister’s Office (PMO) mentioned. The programme goals to ability and upskill over one lakh “Covid warriors” throughout the nation, the PM’s Office mentioned.
-
The Serum Institute of India, which is making ready to provide Novavax’s COVID-19 vaccine within the nation underneath the title Covovax, plans to begin trials of the vaccine on youngsters subsequent month, sources within the firm instructed NDTV on Thursday.
-
Biological E’s made-in-India vaccine is predicted to have 90 per cent effectiveness in opposition to Covid and can possible be a gamechanger within the battle in opposition to the pandemic, says a prime physician on a authorities advisory panel. NK Arora, chairperson of the Centre’s Covid Working Group, has mentioned that the vaccine is getting into Phase 3 trials and might be accessible by October.
-
The Uttarakhand authorities on Thursday lodged a case in opposition to an organization and two personal labs for fudging coronavirus take a look at reviews in the course of the Haridwar Kumbh Mela in April.
-
A commentary on the web site of the medical journal The Lancet authored by 21 individuals, together with Biocon’s Kiran Mazumdar Shaw and prime surgeon Dr Devi Shetty, has really useful eight actions to organize for a potential resurgence of COVID-19 circumstances in India.
-
The Russian Direct Investment Fund (RDIF) has mentioned its Covid vaccine Sputnik V will quickly provide a booster shot or the second dose of the vaccine, which has been adjusted to work in opposition to the Delta variant of coronavirus, to different vaccine producers. In April, Sputnik obtained emergency use authorisation in India, making it the third vaccine to be made accessible within the nation.
